Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What are the challenges with multi-targeted drug design for complex diseases?
Agata Zięba, Piotr Stępnicki, Dariusz Matosiuk, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 7, pp. 673-683
Closed Access | Times Cited: 23

Showing 23 citing articles:

Network pharmacology approaches for research of Traditional Chinese Medicines
Xiang Li, Ziqi LIU, Jie Liao, et al.
Chinese Journal of Natural Medicines (2023) Vol. 21, Iss. 5, pp. 323-332
Closed Access | Times Cited: 150
Targeting the PI3K/AKT/mTOR Signaling Pathway in the Treatment of Human Diseases: Current Status, Trends, and Solutions
Jindi Huang, Liye Chen, Jiangxia Wu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16033-16061
Closed Access | Times Cited: 73
AlphaFold2 protein structure prediction: Implications for drug discovery
Neera Borkakoti, Janet M. Thornton
Current Opinion in Structural Biology (2023) Vol. 78, pp. 102526-102526
Open Access | Times Cited: 57
Polypharmacology: promises and new drugs in 2022
Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 755-770
Open Access | Times Cited: 27
Multi-Target Profiling of Antioxidant Compounds, Including Repurposing and Combination Strategies
Roberta Rocca
Antioxidants (2025) Vol. 14, Iss. 2, pp. 220-220
Open Access
Multi-and many-objective optimization: present and future in de novo drug design
Jaqueline S. Angelo, Isabella Alvim Guedes, Hélio J. C. Barbosa, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 10
Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics Approach
Ilaria Granata, Paola Barboro
Biomolecules (2024) Vol. 14, Iss. 1, pp. 87-87
Open Access | Times Cited: 2
In-silico design novel phenylsulfonyl furoxan and phenstatin derivatives as multi-target anti-cancer inhibitors based on 2D-QSAR, molecular docking, dynamics and ADMET approaches
Abdelmadjid Guendouzi, Lotfi Belkhırı, Farah Djelti, et al.
Molecular Simulation (2024) Vol. 50, Iss. 6, pp. 470-492
Open Access | Times Cited: 2
Recent advances in dual PROTACs degrader strategies for disease treatment
Jianyu Liu, Yanzhuo Liu, Jiao Tang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116901-116901
Closed Access | Times Cited: 2
Exploring the Antidiabetic Potential of Salvia officinalis Using Network Pharmacology, Molecular Docking and ADME/Drug-Likeness Predictions
Chimaobi James Ononamadu, Véronique Seidel
Plants (2024) Vol. 13, Iss. 20, pp. 2892-2892
Open Access | Times Cited: 2
CADMA-Chem: A Computational Protocol Based on Chemical Properties Aimed to Design Multifunctional Antioxidants
Eduardo Gabriel Guzmán‐López, Miguel Reina, Adriana Pérez‐González, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13246-13246
Open Access | Times Cited: 12
Integrative Pharmacology in the Treatment of Substance Use Disorders
Jack Donlon, Pooja Kumari, Sajoy P. Varghese, et al.
Journal of Dual Diagnosis (2023) Vol. 20, Iss. 2, pp. 132-177
Closed Access | Times Cited: 6
Optimizing drug discovery using multitasking models for quantitative structure–biological effect relationships: an update of the literature
Valeria V. Kleandrova, M. Natália D. S. Cordeiro, Alejandro Speck‐Planche
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 11, pp. 1231-1243
Closed Access | Times Cited: 5
Synthesis, biological evaluation, and stability studies of raloxifene mono- and bis-sulfamates as dual-targeting agents
Seyed–Omar Zaraei, Wolfgang Döhle, Hanan S. Anbar, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 101, pp. 117645-117645
Closed Access | Times Cited: 1
Genomic Insights into Dementia: Precision Medicine and the Impact of Gene-Environment Interaction
Anjali Tripathi, Vinay Kumar Pandey, Garima Sharma, et al.
Aging and Disease (2024) Vol. 15, Iss. 5, pp. 2113-2113
Open Access | Times Cited: 1
Thymoquinone-rich black cumin oil attenuates ibotenic acid-induced excitotoxicity through glutamate receptors in Wistar rats
Sibi P. Ittiyavirah, R Kannan, Arathy Sathyan, et al.
Saudi Pharmaceutical Journal (2022) Vol. 30, Iss. 12, pp. 1781-1790
Open Access | Times Cited: 6
Multitargeting the Action of 5-HT6 Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer’s Disease: Can It Work from a Molecular Point of View?
Kinga Czarnota-Łydka, Katarzyna Kucwaj‐Brysz, Patryk Pyka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8768-8768
Open Access | Times Cited: 5
Multi-Objective and Many-Objective Optimisation: Present and Future in de novo Drug Design
Jaqueline S. Angelo, Isabella Alvim Guedes, Hélio J. C. Barbosa, et al.
(2023)
Open Access | Times Cited: 2
Synthesis and Biological Evaluation of Novel Chlorogenic Acid–Apigenin Conjugates as Anti-acute Gout Agents
Changjiang Xu, Ling Li, Zheng Liu, et al.
Chemical and Pharmaceutical Bulletin (2024) Vol. 72, Iss. 8, pp. 751-761
Open Access
Lipidomics-driven drug discovery and delivery strategies in glioblastoma
Xiaohui Weng, Michael Gonzalez, Jeannes Angelia, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 3, pp. 167637-167637
Open Access
Overcoming the Challenges of Multi‐Target‐Directed Ligands for Alzheimer's Disease
Elisa Uliassi, Anna Pasieka, Eleonora Diamanti, et al.
(2024), pp. 193-201
Closed Access
Multitargeting in cardioprotection: An example of biaromatic compounds
Г. В. Мокров
Archiv der Pharmazie (2023) Vol. 356, Iss. 9
Closed Access | Times Cited: 1
Multi- and Many-Objective Optimisation: Present and Future in de novo Drug Design
Jaqueline S. Angelo, Isabella Alvim Guedes, Hélio J. C. Barbosa, et al.
(2023)
Open Access
Page 1

Scroll to top